Recent Antiphospholipid Syndrome News:
- The Critical Importance of Diagnosing Atypical Hemolytic Uremic Syndrome in Postpartum …
- Utility and Sensitivity of TLR10 Gene Polymorphism in Early Prediction and Association with …
- Lack of adequate mental health care in inflammatory arthritis ‘needs to be addressed’
- Silica dust, heavy metal, solvents may contribute to myositis with lung involvement – Healio
- Upadacitinib, deucravacitinib ‘the top two’ small molecules for psoriatic arthritis – Healio
- ‘Alternative’ markers of insulin resistance can predict osteoarthritis – Healio
- Secondary Severe Factor X Deficiency Associated with Antiphospholipid Syndrome
- Exploring Biomarkers to Predict Thrombogenic Risk in Pregnancy – ResearchGate
- Stroke Prevention Day: “I was fit, strong and healthy, and my first stroke was very unexpected”
- Blood pressure check could save your life says Bristol stroke survivor – BristolWorld
- Global Catastrophic Antiphospholipid Syndrome Market Survey – openPR.com
- A Case of Three Upper Extremity Lesions of Mobile Encapsulated Fat Necrosis in One Patient
- Polymyositis-Like Myopathy With Anti-PL-12 Antibody Positivity and Coexisting …
- Antiphospholipid Syndrome And Associated Autoimmune Disorders | Nature Research Intelligence
- Navigating antiphospholipid syndrome: from personalized therapies to cutting-edge research
- Mira-Bhayandar: 26-Year-Old Woman With Catastrophic APLA Syndrome Delivers Healthy …
- Antiphospholipid Syndrome (APS) Market: Company Profiles, – openPR.com
- Mira Road: Mother, preterm baby survive rare life-threatening disorder in high-risk pregnancy
- Diagnosis and management of antiphospholipid syndrome – Australian Prescriber
- Hydroxychloroquine Market to Reach USD 11,764 Million by 2032
- Democrat Staffers Push To Reduce Full-Time Work Week To 32 Hours – The Daily Wire
- Frailty in systemic sclerosis increases mortality risk nearly 10 times – Healio
- Duloxetine, milnacipran and pregabalin improve fibromyalgia pain for one in 10 patients
- Early subclinical macular disease in asymptomatic patients with primary antiphospholipid syndrome
- Your Sinusitis May Increase Your Risk Of Autoimmune Disease By 40 Per Cent, Finds Study
- From cardiac arrest to respiratory failure, a mother’s fight to stay alive – WMAR
- Werfen Receives FDA 510(k) Clearance for Antiphospholipid Syndrome Test Reagents
- Exagen Posts Flat to Slight Decline in Preliminary Q4 Report, Gets Conditional NY Approval
- Werfen Receives US FDA 510(k) Clearance for Aptiva® Antiphospholipid Syndrome Reagents
- Multiple Violations Found At McDonald’s Onion Supplier After Deadly E.Coli Outbreak
- First-Time Moms In This State May Be Using Welfare for Paid Family Leave – WFMZ.com
- Planet Fitness Announces Key Year-End Metrics – Le Lézard
- Antiphospholipid Antibodies Linked to Increased Risk for Diffuse Alveolar Hemorrhage in SLE
- Tendonitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, – openPR.com
- Botulinum toxin reduces pain, disability in Raynaud’s syndrome secondary to scleroderma
- Ewing Sarcoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, – openPR.com
- Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on …
- My Pain Was Ignored For Almost a Year: Caitlin’s Story – National Blood Clot Alliance
- Clinical and Immunologic Manifestations of Antiphospholipid Syndrome Among Patients in …
- A holistic approach is needed for women with an inflammatory arthritis in the different … – Frontiers
- (PDF) Case Report: Primary catastrophic antiphospholipid syndrome in a pediatric patient …
- Impact of antiphospholipid syndrome on placenta and uterine NK cell function – Nature
- Cancer History, Antiphospholipid Syndrome, and Lupus Anticoagulant: A Perfect Storm for …
- Antiphospholipid Syndrome Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA …
- This Ridiculously Cheap Warren Buffett Stock Could Make You Richer – The Globe and Mail
- NCCN Funds Research to Address Side Effects of PARP Inhibitors in Prostate Cancer Treatment
- Risk factors associated with pregnancy outcomes in patients with recurrent pregnancy loss …
- Cutaneous Microthrombosis in a Patient With Factor V Leiden Heterozygosity and … – Cureus
- Galactosemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, – openPR.com
- A Case of Eltrombopag-Induced Thrombotic Microangiopathy Initiating Hemodialysis
Antiphospholipid Syndrome News:
- Nine research updates in thrombosis treatment, surveillance and risk prediction.
-
Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.
-
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.
-
Heart attack: New finding may change the face of treatment
-
Hughes syndrome (antiphospholipid syndrome) and the nervous system.
-
When autoimmune diseases exert neuro-ophthalmic effects
-
Catastrophic antiphospholipid syndrome: The current management approach.
- 2016 review on catastrophic antiphospholipid syndrome.
-
Pregnancy and APS: Results Look Encouraging
-
The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome
-
Anticoagulating patients with high-risk acquired thrombophilias.
-
Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE
-
Catastrophic antiphospholipid syndrome: The current management approach.
- Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome. case report
- C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
- Myasthenia gravis is sometimes found in conjunction with antiphospholipid syndrome with: A case report
- Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
- Good news for prospective mothers with antiphospholipid syndrome? – Journal of Postgraduate Medicine
- New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases
- Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist
- Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review